All 'Bout That 'Mo


  • Jason Goepfert

    Jason Goepfert

    Published: 2019-12-02 at 12:09:04 CST

This is an abridged version of our recent reports and notes. For immediate access with no obligation, sign up for a 30-day free trial now.


Momentum

With just one month left this year, U.S. equities have rallied significantly year-to-date. U.S. equity indices like the NASDAQ Composite have gone up 9 of the past 11 months.

As is the case with most momentum studies, this has been typically bullish for stocks over the coming months:

That doesn't necessarily fit with some of the warning signs we're seeing out there, but those are mostly shorter-term.


More momentum: MACD

Various U.S. stock market indices' monthly MACD histograms have turned positive for the first time in months. This includes the NASDAQ Composite (which we touched on last week), and now the Dow Jones Industrial Average and NYSE Composite.

Like the Nasdaq, the NYSE Composite's monthly MACD has turned positive for the first time in > 1 year.

Extreme momentum usually does not simply stop on a dime.

We also looked at:

  • Our medium-term Risk Level is extremely high
  • What the persistently low Goldman Current Activity Indicator might mean
  • More looks at price momentum

The post titled All 'Bout That 'Mo was originally published as on SentimenTrader.com on 2019-12-02.

At SentimenTrader.com, our service is not focused on market timing per se, but rather risk management. That may be a distinction without a difference, but it's how we approach the markets. We study signs that suggest it is time to raise or lower market exposure as a function of risk relative to probable reward. It is all about risk-adjusted expectations given existing evidence. Learn more about our service , research, models and indicators.


Follow us on Twitter for up to the minute analysis of market action.